Drug discovery is an essential part of the drug development process. Testing in drug discovery is the mechanism to provide drug candidates that are selected for regulated animal studies and hopefully moving into clinical trials. Bioanalytical drug discovery includes a wide range of tests including assessment of a compound’s physiochemical properties, metabolite screening, bioavailability, toxicity and pharmacokinetics.
KCAS brings the full power of LBA and LC-MS/MS to your Drug Discovery projects
KCAS offers superiors Ligand Binding Assay work – which continues to be the primary tool used in the biopharmaceutical sciences to quantitate proteins and anti-drug antibodies in biological fluids and tissues – but one of KCAS’ core expertise is using bioanalytical LC-MS/MS to support drug discovery, particularly in assessing bioavailability and pharmacokinetic work. We can help with study design and do the actual TK assessment once the bioanalytical data are available.